title: Imatinib is effective for prevention and improvement of fibrotic fasciitis as a manifestation of chronic GVHD.
authors.forename: T
authors.initials: T
authors.lastname: Osumi
authors.forename: M
authors.initials: M
authors.lastname: Miharu
authors.forename: R
authors.initials: R
authors.lastname: Tanaka
authors.forename: W
authors.initials: W
authors.lastname: Du
authors.forename: T
authors.initials: T
authors.lastname: Takahashi
authors.forename: H
authors.initials: H
authors.lastname: Shimada
mesh_terms: D000293:Adolescent; D001549:Benzamides; D016026:Bone Marrow Transplantation; D002908:Chronic Disease; D005208:Fasciitis / Q000473:pathology / Q000517:prevention & control*; D005355:Fibrosis; D006086:Graft vs Host Disease / Q000473:pathology / Q000517:prevention & control*; D006801:Humans; D000068877:Imatinib Mesylate; D008297:Male; D010879:Piperazines / Q000008:administration & dosage*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000473:pathology / Q000628:therapy; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage*; D014184:Transplantation, Homologous
chemical_list: D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate